| |  Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science behind these emerging strategies. | |
|
| |  Understanding the cancer ecosystem reveals tumor microenvironment interactions, offering new insights for precision oncology and immunotherapy advancements. | |
|
| |  A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive review in ExRNA that sorts out the diverse roles of extracellular vesicle-associated RNAs (EV-RNAs) in the development and progression of inflammatory bowel disease (IBD). | |
|
| |  Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate. | |
|
| |  A national survey study led by UCLA Health and Cedars-Sinai Medical Center found significant disparities in how irritable bowel syndrome, or IBS, is diagnosed across sex and racial groups in the U.S., with men and Black patients considerably less likely than women and white patients to receive a formal diagnosis. | |
|
| |  Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells. | |
|
| | It is safe for patients to receive a donor liver that has been intentionally preserved overnight using machine perfusion to enable a daytime transplant. | |
|
| | Advanced liver disease (ALD) occurs when significant scarring causes the liver to lose function. Patients with ALD often have serious health challenges but have limited access to palliative care that could improve their quality of life. | |
|
| | A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant Clostridioides difficile (C. difficile) infection - a life-threatening condition characterized by a sepsis-like state. | |
|
| | A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE) related dysplasia and early esophageal adenocarcinoma. | |
